Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.
about
Outer membrane vesicles displaying engineered glycotopes elicit protective antibodiesCan Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?Review of meningococcal group B vaccines.The Therapeutic Benefit of Bacterial Membrane Vesicles.Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica.Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae.Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvantPopulation structure in the Neisseria, and the biological significance of fuzzy speciesProtective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.The epidemiology of meningococcal disease and the impact of vaccines.Microbial biosynthesis of designer outer membrane vesicles.Novel approaches to Neisseria meningitidis vaccine design.Inactivation of NMB0419, Encoding a Sel1-Like Repeat (SLR) Protein, in Neisseria meningitidis Is Associated with Differential Expression of Genes Belonging to the Fur Regulon and Reduced Intraepithelial Replication.New plasmid tools for genetic analysis of Actinobacillus pleuropneumoniae and other pasteurellaceae.Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa.
P2860
Q28831290-1B4A42D2-92B6-47DC-814F-E21477CEE5E0Q30150784-46BE787D-940C-43D8-B63D-CED3E726EBBFQ33646965-5C1D64CB-0D9D-4AF1-A03E-6690B4AE128DQ33839021-B982F3FE-0E1E-4FB5-BE1F-FC2732AEEAB6Q34058392-21B72C11-5CAC-43F0-8C9A-D7A84525FC99Q34529570-B5A4B137-E3F9-42E0-912E-36EBC49A19D3Q35887397-ADB582A3-D638-478A-8031-541067F5AB05Q35954300-DAFA2312-895A-40DF-98A8-EDB923B1144CQ36638451-DB69F6CC-345B-4443-9994-73E7C62AC2D3Q37033059-D2C73CBC-2266-429F-A911-3A5FAAA8AA42Q37706585-ED9C3738-DE1D-4256-8240-FA994C65F981Q38199270-81340090-DF9E-41B6-A5C3-60956A945B08Q39215403-EB502E33-A84E-4E2D-ADE5-9D8F2FEF6186Q40306129-E3C2CCB3-D468-45F2-9745-C9232FB1FBACQ42570229-2AF3B6B4-9D71-4E92-9733-35DBE836B546Q45057875-84ADF4CA-D59B-43D8-B788-11B78BBFBF45
P2860
Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Expression of heterologous ant ...... itopes with vaccine potential.
@en
Expression of heterologous ant ...... itopes with vaccine potential.
@nl
type
label
Expression of heterologous ant ...... itopes with vaccine potential.
@en
Expression of heterologous ant ...... itopes with vaccine potential.
@nl
prefLabel
Expression of heterologous ant ...... itopes with vaccine potential.
@en
Expression of heterologous ant ...... itopes with vaccine potential.
@nl
P2093
P2860
P1476
Expression of heterologous ant ...... pitopes with vaccine potential
@en
P2093
Bernard R Brodeur
Clíona A O'dwyer
Denis Martin
J Simon Kroll
Karen Reddin
Michael J Hudson
Stephen C Taylor
P2860
P304
P356
10.1128/IAI.72.11.6511-6518.2004
P407
P577
2004-11-01T00:00:00Z